Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$69.25 - $82.21 $20,775 - $24,662
-300 Reduced 82.19%
65 $4,000
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $17,523 - $27,105
300 Added 461.54%
365 $26,000
Q4 2022

Feb 15, 2023

BUY
$39.94 - $79.72 $2,596 - $5,181
65 New
65 $5,000
Q4 2021

Feb 16, 2022

SELL
$30.7 - $43.36 $61 - $86
-2 Closed
0 $0
Q1 2021

Aug 17, 2021

BUY
$55.91 - $81.44 $55 - $81
1 Added 100.0%
2 $0
Q1 2021

May 12, 2021

BUY
$55.91 - $81.44 $55 - $81
1 New
1 $0

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.